Anavex Life Sciences Stock Current Valuation
AVXL Stock | USD 9.57 0.13 1.34% |
Valuation analysis of Anavex Life Sciences helps investors to measure Anavex Life's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that Anavex Life's price fluctuation is relatively risky at this time. Calculation of the real value of Anavex Life Sciences is based on 3 months time horizon. Increasing Anavex Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Anavex stock is determined by what a typical buyer is willing to pay for full or partial control of Anavex Life Sciences. Since Anavex Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anavex Stock. However, Anavex Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 9.57 | Real 8.48 | Hype 9.57 | Naive 9.56 |
The intrinsic value of Anavex Life's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Anavex Life's stock price.
Estimating the potential upside or downside of Anavex Life Sciences helps investors to forecast how Anavex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anavex Life more accurately as focusing exclusively on Anavex Life's fundamentals will not take into account other important factors: Anavex Life Sciences Company Current Valuation Analysis
Anavex Life's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Anavex Life Current Valuation | 690.52 M |
Most of Anavex Life's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Anavex Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Anavex Life Sciences has a Current Valuation of 690.52 M. This is 95.19% lower than that of the Biotechnology sector and 85.14% lower than that of the Health Care industry. The current valuation for all United States stocks is 95.85% higher than that of the company.
Anavex Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Anavex Life's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Anavex Life could also be used in its relative valuation, which is a method of valuing Anavex Life by comparing valuation metrics of similar companies.Anavex Life is currently under evaluation in current valuation category among its peers.
Anavex Fundamentals
Return On Equity | -0.3 | ||||
Return On Asset | -0.2 | ||||
Current Valuation | 690.52 M | ||||
Shares Outstanding | 84.82 M | ||||
Shares Owned By Insiders | 3.04 % | ||||
Shares Owned By Institutions | 32.03 % | ||||
Number Of Shares Shorted | 23.4 M | ||||
Price To Earning | (11.03) X | ||||
Price To Book | 6.84 X | ||||
EBITDA | (47.5 M) | ||||
Net Income | (43 M) | ||||
Cash And Equivalents | 149.16 M | ||||
Cash Per Share | 1.91 X | ||||
Total Debt | 15.3 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 14.95 X | ||||
Book Value Per Share | 1.53 X | ||||
Cash Flow From Operations | (30.81 M) | ||||
Short Ratio | 10.82 X | ||||
Earnings Per Share | (0.52) X | ||||
Target Price | 35.97 | ||||
Number Of Employees | 40 | ||||
Beta | 0.6 | ||||
Market Capitalization | 811.68 M | ||||
Total Asset | 135.57 M | ||||
Retained Earnings | (336.07 M) | ||||
Working Capital | 120.26 M | ||||
Current Asset | 9.45 M | ||||
Current Liabilities | 3.19 M | ||||
Net Asset | 135.57 M |
About Anavex Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anavex Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anavex Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anavex Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Anavex Life Piotroski F Score and Anavex Life Altman Z Score analysis. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Business Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.